Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists

(MedPage Today) -- Several years after initiating treatment, GLP-1 receptor agonist users didn't have a pancreatic cancer safety signal, a historical cohort study reported. Compared with basal insulin users, those on a GLP-1 receptor agonist didn...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news